Actively Recruiting

Phase Not Applicable
Age: 18Years - 35Years
FEMALE
NCT06793904

Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS

Led by Cairo University · Updated on 2025-02-05

122

Participants Needed

1

Research Sites

47 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

122 women diagnosed with PCOS seeking fertility in the fertility clinic at kasr Alainy hospital will be subjected to Homeostatic model assessment for insulin resistance 1 was calculated for all participants through the equation \[glucose (mmol/L) × insulin (µU/L)\]/22.5 while homeostatic model assessment for insulin resistance 2 was calculated by the HOMA2 calculator. All women will be subjected to induction of ovulation using the Aromatase inhibitor Letrozole 2.5 mg tab twice daily from the 3rd day of the cycle for 5 days . Ultrasound follow up of follicular growth will be performed till dominant follicular size reaches 18-22 mm. FSH preparations will be introduced as needed.

CONDITIONS

Official Title

Comparative Study Between HOMA1-IR and HOMA2-IR in Prediction of Ovulation Outcome in Women With PCOS

Who Can Participate

Age: 18Years - 35Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Age 18-35 years
  • Duration of infertility 1-4 years
  • Diagnosis of Polycystic Ovarian Syndrome (PCOS)
Not Eligible

You will not qualify if you...

  • Women with other causes of infertility such as tubal factor, uterine cavity abnormalities, or male factor
  • Endometriosis
  • Ovarian cysts
  • Endocrinological abnormalities including diabetes mellitus, hypothalamic, pituitary, thyroid disorders, or hyperprolactinemia
  • History of poor ovarian response or ovarian hyperstimulation
  • Chronic diseases, chromosomal, autoimmune or coagulation defects, abnormal leucocytic count or other inflammatory markers
  • Women with contraindications to pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Kasr Alainy medical school

Cairo, Egypt, 12111

Actively Recruiting

Loading map...

Research Team

A

Ahmed Maged, MD

CONTACT

A

Ahmed Chamel, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

DIAGNOSTIC

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here